Preparation and MRI Study of HER2-Targeted Bimodal Molecular Probe Gd-Cy5.5-Pertuzumab for Thyroid Cancer

Figure 3

(a) UV–vis absorption spectra of Gd-DOTA, pertuzumab, and Gd-Cy5.5-pertuzumab; (b) infrared spectra of Gd-Cy5.5-pertuzumab.

(a)

(b)